Targeting innate immunity for neurodegenerative disorders of the central nervous system

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Neurochemistry

• Publication date

  2016-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jnc.13667PMID 27248001PMCID PMC5433264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripheral Immune Signatures in Alzheimer Disease.

  2016cited by this paper
• Reactive gliosis in the pathogenesis of CNS diseases.

  2016cited by this paper
• Head Injury in an Age-Related Alzheimer Mouse Model Leads to an Altered Neuroinflammatory Response and Persistent Cognitive Impairment

  2016cited by this paper
• Nucleosomes impede Cas9 access to DNA in vivo and in vitro

  2016cited by this paper
• Astrocytes: a central element in neurological diseases

  2016cited by this paper
• Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy

  2015cited by this paper
• Microglial Dynamics and Role in the Healthy and Diseased Brain

  2015cited by this paper
• Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System.

  2015cited by this paper
• Innate Immunity Fights Alzheimer's Disease.

  2015cited by this paper
• Neuroinflammation: Ways in Which the Immune System Affects the Brain

  2015cited by this paper
• Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease.

  2015cited by this paper
• Attenuation of traumatic brain injury-induced cognitive impairment in mice by targeting increased cytokine levels with a small molecule experimental therapeutic

  2015cited by this paper
• Arginine Deprivation and Immune Suppression in a Mouse Model of Alzheimer's Disease

  2015cited by this paper
• Loss of tau rescues inflammation-mediated neurodegeneration

  2015cited by this paper
• Bone Marrow-Derived Macrophages from AβPP/PS1 Mice are Sensitized to the Effects of Inflammatory Stimuli

  2015cited by this paper
• RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.

  2015cited by this paper
• Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells.

  2015cited by this paper
• Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β.

  2015cited by this paper
• Microglial brain region-dependent diversity and selective regional sensitivities to ageing

  2015cited by this paper
• Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement Therapies

  2015cited by this paper
• Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.

  2015cited by this paper
• Immune attack: the role of inflammation in Alzheimer disease

  2015cited by this paper
• Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s Disease

  2015cited by this paper
• Nuclear Receptors License Phagocytosis by Trem2+ Myeloid Cells in Mouse Models of Alzheimer's Disease

  2015cited by this paper
• Closed Head Injury in an Age-Related Alzheimer Mouse Model Leads to an Altered Neuroinflammatory Response and Persistent Cognitive Impairment

  2015cited by this paper
• Bone marrow-derived macrophages from aged rats are more responsive to inflammatory stimuli

  2015cited by this paper
• Disease-related microglia heterogeneity in the hippocampus of Alzheimer’s disease, dementia with Lewy bodies, and hippocampal sclerosis of aging

  2015cited by this paper
• Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.

  2015cited by this paper
• Hallmarks of pluripotency

  2015cited by this paper
• Microglia Versus Myeloid Cell Nomenclature during Brain Inflammation

  2015cited by this paper
• Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease–like mice

  2015cited by this paper
• The Contributing Role of Lipid Peroxidation and Protein Oxidation in the Course of CNS Injury Neurodegeneration and Neuroprotection

  2015cited by this paper
• TREM2 in CNS homeostasis and neurodegenerative disease

  2015cited by this paper
• IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.

  2015cited by this paper
• Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer’s disease

  2015cited by this paper
• Astrocyte barriers to neurotoxic inflammation

  2015cited by this paper
• TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model

  2015cited by this paper
• Differentiation of Donor-Derived Cells Into Microglia After Umbilical Cord Blood Stem Cell Transplantation

  2015cited by this paper
• Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1β, BDNF and synaptic plasticity.

  2015cited by this paper
• Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation

  2015cited by this paper
• T Cells—Protective or Pathogenic in Alzheimer’s Disease?

  2015cited by this paper
• Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models

  2015cited by this paper
• Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.

  2015cited by this paper
• Dual polarization of microglia isolated from mixed glial cell cultures

  2015cited by this paper
• C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages.

  2015cited by this paper
• Microglial malfunction: the third rail in the development of Alzheimer's disease.

  2015cited by this paper
• Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1β in the aged hippocampus

  2015cited by this paper
• TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models

  2015cited by this paper
• Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease

  2015cited by this paper
• Cellular factors modulating the mechanism of tau protein aggregation

  2015cited by this paper
• Etanercept in Alzheimer disease

  2015cited by this paper
• Neuronal and microglial regulators of cortical wiring: usual and novel guideposts

  2015cited by this paper
• CCR2 Antagonism Alters Brain Macrophage Polarization and Ameliorates Cognitive Dysfunction Induced by Traumatic Brain Injury

  2015cited by this paper
• Inhibition of JAK2 attenuates the increase in inflammatory markers in microglia from APP/PS1 mice.

  2015cited by this paper
• Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.

  2015cited by this paper
• Origin of microglia: current concepts and past controversies.

  2015cited by this paper
• Innate immunity in Alzheimer's disease

  2015cited by this paper
• Lost in translation: pluripotent stem cell-derived hematopoiesis

  2015cited by this paper
• Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

  2015cited by this paper
• Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice*

  2015cited by this paper
• Present and future challenges of induced pluripotent stem cells

  2015cited by this paper
• Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington's disease.

  2015cited by this paper
• Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior

  2014cited by this paper
• Accelerated microglial pathology is associated with Aβ plaques in mouse models of Alzheimer’s disease

  2014cited by this paper
• Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences.

  2014cited by this paper
• Microglial priming in neurodegenerative disease

  2014cited by this paper
• Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain.

  2014cited by this paper
• The Evolving Biology of Microglia in Alzheimer’s Disease

  2014cited by this paper
• Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy

  2014cited by this paper
• A Novel Method for Three-Dimensional Culture of Central Nervous System Neurons

  2014cited by this paper
• Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation

  2014influential reference
• Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP/PS1 mice.

  2014cited by this paper
• Interleukin-1β mediated amyloid plaque clearance is independent of CCR2 signaling in the APP/PS1 mouse model of Alzheimer's disease.

  2014cited by this paper
• Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2

  2014cited by this paper
• Environment drives selection and function of enhancers controlling tissue-specific macrophage identities.

  2014cited by this paper
• Innate immune activation in neurodegenerative disease

  2014cited by this paper
• Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature

  2014cited by this paper
• Nuclear receptors in neurodegenerative diseases.

  2014cited by this paper
• Microglia modulate wiring of the embryonic forebrain.

  2014cited by this paper
• Altered arginine metabolism in Alzheimer's disease brains.

  2014cited by this paper
• CCR2 Deficiency Impairs Macrophage Infiltration and Improves Cognitive Function after Traumatic Brain Injury

  2014cited by this paper
• Diversity of amino acid signaling pathways on autophagy regulation: a novel pathway for arginine.

  2014cited by this paper
• Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell Therapy

  2014cited by this paper
• Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice.

  2014cited by this paper
• Wnt Signaling Controls the Specification of Definitive and Primitive Hematopoiesis From Human Pluripotent Stem Cells

  2014cited by this paper
• IL-4 Signaling Drives a Unique Arginase+/IL-1β+ Microglia Phenotype and Recruits Macrophages to the Inflammatory CNS: Consequences of Age-Related Deficits in IL-4Rα after Traumatic Spinal Cord Injury

  2014cited by this paper
• Monocytes and macrophages: developmental pathways and tissue homeostasis

  2014influential reference
• Astrocyte reactivity and reactive astrogliosis: costs and benefits.

  2014cited by this paper
• Suppression of Alzheimer-Associated Inflammation by Microglial Prostaglandin-E2 EP4 Receptor Signaling

  2014cited by this paper
• Meta-analysis of the association between CR1 polymorphisms and risk of late-onset Alzheimer's disease.

  2014cited by this paper
• Microglial pathology

  2014cited by this paper
• The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages

  2014cited by this paper
• Endogenous polyamine function—the RNA perspective

  2014cited by this paper
• The human side of microglia.

  2014cited by this paper
• HB‐EGF affects astrocyte morphology, proliferation, differentiation, and the expression of intermediate filament proteins

  2014cited by this paper
• In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

  2013cited by this paper
• Inflammation and white matter degeneration persist for years after a single traumatic brain injury.

  2013cited by this paper
• Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways

  2013cited by this paper
• Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology

  2013cited by this paper
• Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner

  2013cited by this paper

• Astrocyte-mediated inflammatory responses in traumatic brain injury: mechanisms and potential interventions

  2025cites this paper
• Advances in the Study of Small Cell Lung Cancer and Metabolic Syndrome

  2025cites this paper
• Traumatic brain injury and Alzheimer's disease related neurodegenerative diseases: Insights from animal models.

  2025cites this paper
• Traumatic Brain Injury as a Risk Factor for Alzheimer’s Disease and Potential for Pathogenetic Therapy

  2024cites this paper
• [Traumatic brain injury as risk factor of Alzheimer's disease and possibilities of pathogenetic therapy].

  2024cites this paper
• Gut Microbiota-Immune System Interactions in Health and Neurodegenerative Diseases: Insights into Molecular Mechanisms and Therapeutic Applications

  2024cites this paper
• TLR4-mediated chronic neuroinflammation has no effect on tangle pathology in a tauopathy mouse model

  2024cites this paper
• Intermittent fasting alleviates postoperative cognitive dysfunction by reducing neuroinflammation in aged mice.

  2024cites this paper
• A small molecule p38α MAPK inhibitor, MW150, attenuates behavioral deficits and neuronal dysfunction in a mouse model of mixed amyloid and vascular pathologies

  2024cites this paper
• The roles of AIM2 in neurodegenerative diseases: insights and therapeutic implications

  2024cites this paper
• CHIT1-positive microglia act as culprits for spinal motor neuron aging

  2024cites this paper
• New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease

  2023cites this paper
• CHIT1-positive microglia drive motor neuron ageing in the primate spinal cord

  2023cites this paper
• A blunted TH17 cytokine signature in women with mild cognitive impairment: insights from inflammatory profiling of a community-based cohort of older adults

  2023cites this paper
• Neuroprotective effects of hesperetin on H2O2-induced damage in neuroblastoma SH-SY5Y cells

  2023cites this paper
• Reversing memory/cognitive impairment with medicinal plants targeting inflammation and its crosstalk with other pathologies

  2023cites this paper
• The localization of molecularly distinct microglia populations to Alzheimer's disease pathologies using QUIVER

  2023cites this paper
• Potential of astrocytes in targeting therapy for Alzheimer's disease.

  2022cites this paper
• SARM suppresses glioma progression in GL261 glioma cells and regulates microglial polarization

  2022cites this paper
• YY1 PROMOTES MICROGLIA M2 POLARIZATION THROUGH THE MIR-130A-3P/TREM-2 AXIS TO ALLEVIATE SEPSIS-ASSOCIATED ENCEPHALOPATHY

  2022cites this paper
• Systemic Response to Infection Induces Long-Term Cognitive Decline: Neuroinflammation and Oxidative Stress as Therapeutical Targets

  2022cites this paper
• The Role of Non-canonical and Canonical Inflammasomes in Inflammaging

  2022cites this paper
• In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration

  2022cites this paper
• Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders

  2022cites this paper
• Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects

  2022cites this paper
• Induced pluripotent stem cell technology for spinal cord injury: a promising alternative therapy

  2021cites this paper
• N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

  2021cites this paper
• Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease

  2021cites this paper
• Microglia Specific Drug Targeting Using Natural Products for the Regulation of Redox Imbalance in Neurodegeneration

  2021cites this paper
• Microglia and modifiable life factors: Potential contributions to cognitive resilience in aging.

  2021cites this paper
• Lycopene and Chrysin through Mitigation of Neuroinflammation and Oxidative Stress Exerted Antidepressant Effects in Clonidine-Induced Depression-like Behavior in Rats

  2021cites this paper
• Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.

  2021cites this paper
• WNT Signaling Is a Key Player in Alzheimer's Disease.

  2021cites this paper
• Acute pre-operative ibuprofen improves cognition in a rat model for postoperative cognitive dysfunction

  2021cites this paper
• Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.

  2021cites this paper
• Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease

  2021cites this paper
• Host Akkermansia muciniphila Abundance Correlates With Gulf War Illness Symptom Persistence via NLRP3-Mediated Neuroinflammation and Decreased Brain-Derived Neurotrophic Factor

  2020cites this paper
• A novel polysaccharide from Acorus tatarinowii protects against LPS-induced neuroinflammation and neurotoxicity by inhibiting TLR4-mediated MyD88/NF-κB and PI3K/Akt signaling pathways.

  2020cites this paper
• Oxidative Stress, a Crossroad between Rare Diseases and Neurodegeneration

  2020cites this paper
• Probiotics ameliorate intestinal pathophysiology in a mouse model of Alzheimer's disease.

  2020cites this paper
• A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice.

  2020cites this paper
• Inhibiting NLRP3 inflammasome with MCC950 ameliorates perioperative neurocognitive disorders, suppressing neuroinflammation in the hippocampus in aged mice.

  2020cites this paper
• Alzheimer’s disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation

  2020cites this paper
• Principles of neuroanatomical architecture supporting brain–immune cell–cell interactions

  2020cites this paper
• Physiological and pathological brain‐immune system interactions

  2020cites this paper
• Curcumin Protects Against Cognitive Impairments in a Rat Model of Chronic Cerebral Hypoperfusion Combined with Diabetes Mellitus by Suppressing Neuroin�ammation, Apoptosis, and Pyroptosis

  2020cites this paper
• Microglia and macrophage metabolism in CNS injury and disease: The role of immunometabolism in neurodegeneration and neurotrauma.

  2020cites this paper
• Curcumin protects against cognitive impairments in a rat model of chronic cerebral hypoperfusion combined with diabetes mellitus by suppressing neuroinflammation, apoptosis, and pyroptosis.

  2020cites this paper
• Anti-neuroinflammatory Effect of Teleogryllus emma Derived Teleogryllusine in LPS-stimulated BV-2 Microglia

  2020cites this paper
• Brain Injury–Mediated Neuroinflammatory Response and Alzheimer’s Disease

  2020cites this paper
• Modeling the Interaction between the Microenvironment and Tumor Cells in Brain Tumors.

  2020cites this paper
• Using the Metabolome to Understand the Mechanisms Linking Chronic Arsenic Exposure to Microglia Activation, and Learning and Memory Impairment

  2020cites this paper
• Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities

  2020cites this paper
• Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice

  2020cites this paper
• Neuroinflammation: A Common Line Between the Wnt Pathway and Toll-Like Receptors

  2020cites this paper
• Metabolomics analysis of the hippocampus in a rat model of traumatic brain injury during the acute phase

  2019cites this paper
• Persistent Malfunction of Glymphatic and Meningeal Lymphatic Drainage in a Mouse Model of Subarachnoid Hemorrhage

  2019cites this paper
• Human pluripotent stem cell–derived models and drug screening in CNS precision medicine

  2019cites this paper
• Studying Heterotypic Cell–Cell Interactions in the Human Brain Using Pluripotent Stem Cell Models for Neurodegeneration

  2019cites this paper
• BDNF-producing, amyloid β-specific CD4 T cells as targeted drug-delivery vehicles in Alzheimer's disease

  2019cites this paper
• Precision Aging: Applying Precision Medicine to the Field of Cognitive Aging

  2019cites this paper
• CD4 T Cells Induce A Subset of MHCII-Expressing Microglia that Attenuates Alzheimer Pathology

  2019cites this paper
• A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation

  2019cites this paper
• Future horizons in Alzheimer's disease research.

  2019cites this paper
• Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells.

  2019cites this paper
• Andrographolide Reduces Neuroinflammation and Oxidative Stress in Aged Octodon degus

  2019cites this paper
• Neurodegenerative diseases as proteinopathies-driven immune disorders

  2019cites this paper
• LXW7 attenuates inflammation via suppressing Akt/nuclear factor kappa B and mitogen-activated protein kinases signaling pathways in lipopolysaccharide-stimulated BV2 microglial cells.

  2019cites this paper
• Progesterone exerts antidepressant-like effect in a mouse model of maternal separation stress through mitigation of neuroinflammatory response and oxidative stress

  2019cites this paper
• Suppression of homeostatic gene expression and increased expression of metabolism-related genes are early features of glaucoma in optic nerve head microglia

  2019cites this paper
• Glia in Health and Disease

  2019cites this paper
• Title Inducible and reversible phenotypes in a novel mouse model of Friedreich ' s Ataxia

  2018cites this paper
• Combined treatment with the phenolics (−)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice

  2018cites this paper
• Inflammation in Alzheimer’s disease: A friend or foe?

  2018cites this paper
• Aβ stimulates microglial activation through antizyme‐dependent downregulation of ornithine decarboxylase

  2018cites this paper
• Drugs targeting intermediate filaments can improve neurosupportive properties of astrocytes.

  2018cites this paper
• Mitochondrial-Directed Antioxidant Reduces Microglial-Induced Inflammation in Murine In Vitro Model of TC-83 Infection

  2018cites this paper
• Direct and indirect pro-inflammatory cytokine response resulting from TC-83 infection of glial cells

  2018cites this paper
• Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease

  2018cites this paper
• Dcf1 Deficiency Attenuates the Role of Activated Microglia During Neuroinflammation

  2018cites this paper
• URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease

  2018cites this paper
• Phosphatidyl-Inositol-3 Kinase Inhibitors Regulate Peptidoglycan-Induced Myeloid Leukocyte Recruitment, Inflammation, and Neurotoxicity in Mouse Brain

  2018cites this paper
• Deconvolution of Human Brain Cell Type Transcriptomes Unraveled Microglia-Specific Potential Biomarkers

  2018cites this paper
• Recent advancements toward therapeutic vaccines against Alzheimer’s disease

  2018cites this paper
• Isolation and Phenotyping of Adult Mouse Microglial Cells.

  2018cites this paper
• Combined treatment with the phenolics (−)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice

  2018cites this paper
• Molecular Basis of Neurodegeneration: Lessons from Alzheimer’s and Parkinson’s Diseases

  2018cites this paper
• TNFα and IL-1β but not IL-18 Suppresses Hippocampal Long-Term Potentiation Directly at the Synapse

  2018cites this paper
• Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link

  2018cites this paper
• The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases

  2018cites this paper
• Let’s make microglia great again in neurodegenerative disorders

  2018cites this paper
• Microglia‐targeted stem cell therapies for Alzheimer disease: A preclinical data review

  2017cites this paper
• Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia

  2017cites this paper
• Effects of cannabidiol interactions with Wnt/&bgr;-catenin pathway and PPAR&ggr; on oxidative stress and neuroinflammation in Alzheimer's disease

  2017cites this paper
• The Alzheimer’s disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons

  2017cites this paper
• Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice.

  2017cites this paper
• A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease

  2017cites this paper
• Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits

  2017cites this paper
• Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice

  2017cites this paper
• iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases.

  2017cites this paper